Research Topics
Species | N MullerSummaryAffiliation: University of Munich Country: Germany Publications
| Collaborators
|
Detail Information
Publications
Neuroimmune-endocrine crosstalk in schizophrenia and mood disordersNorbert Muller
Ludwig Maximilians Universitat Munchen, Hospital for Psychiatry and Psychotherapy, 80336 Munchen, Germany
Expert Rev Neurother 6:1017-38. 2006..The limitations of this concept, however, are critically discussed...
Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspectsNorbert Muller
Department of Psychiatry and Psychotherapy, Ludwig Maximilians University, Nussbaumstr 7, 80336 Munich, Germany
Curr Pharm Des 17:130-6. 2011..Most of the existing data are related to COX-2 inhibitors, which have been tested in animal experiments and in clinical trials, pointing to favourable effects in schizophrenia...
Anti-inflammatory treatment in schizophreniaNorbert Muller
Department of Psychiatry and Psychotherapy, Ludwig Maximilian University, Munich, Germany Electronic address
Prog Neuropsychopharmacol Biol Psychiatry 42:146-53. 2013..Further options for immunomodulating therapies in schizophrenia will be discussed...
Impaired monocyte activation in schizophreniaNorbert Muller
Department of Psychiatry and Psychotherapy, Ludwig Maximilian University, Nussbaumstr 7, 80336 Munich, Germany Electronic address
Psychiatry Res 198:341-6. 2012..The immunological dysfunctions might be associated with a poor clearance of pathogens in schizophrenia, which in turn could lead to a low-grade inflammatory process...
Inflammation in schizophreniaNorbert Muller
Department of Psychiatry and Psychotherapy, Ludwig Maximilians Universitat Munchen, Munchen, Germany
Adv Protein Chem Struct Biol 88:49-68. 2012..Further options for immunomodulating therapies in schizophrenia will be discussed...
Immunological treatment options for schizophreniaNorbert Muller
Department of Psychiatry and Psychotherapy, Ludwig Maximilian University, Nussbaumstr 7, 80336 Munich, Germany
Curr Pharm Biotechnol 13:1606-13. 2012..Further options for immunomodulating therapies in schizophrenia will be discussed...
Altered monocyte activation markers in Tourette's syndrome: a case-control studyJudith Matz
Department of Psychiatry and Psychotherapy, Ludwig Maximilian University, Nussbaumstrasse 7, Munich, Germany
BMC Psychiatry 12:29. 2012..To determine possible common underlying immunological mechanisms, we focused on innate immunity and studied markers of inflammation, monocytes, and monocyte-derived cytokines...
Clinical effects of COX-2 inhibitors on cognition in schizophreniaNorbert Muller
Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Nussbaumstr 7, 80336 Munchen, Germany
Eur Arch Psychiatry Clin Neurosci 255:149-51. 2005..In schizophrenia, the effect on cognition contributes to the therapeutic effect of COX-2 inhibitors...
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetineN Muller
Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Munchen, Germany
Mol Psychiatry 11:680-4. 2006..Moreover, the fact that treatment with an anti-inflammatory drug showed beneficial effects on MD indicates that inflammation is related to the pathomechanism of the disorder, although the exact mechanisms remain to become elucidated...
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidenceNorbert Muller
Ludwig Maximilians Universitat, Department of Psychiatry, Nussbaumstrasse 7, 80336 Munchen, Germany
Curr Opin Investig Drugs 11:31-42. 2010..The potential inflammatory mechanism in schizophrenia and MD, and the possible therapeutic advantages of targeting this mechanism in the treatment of these disorders is discussed in this review...
Schizophrenia genes, epigenetics and psychoneuroimmunology therapeutics: all make sense now?Norbert Muller
Department of Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Munich, Germany
J Psychopharmacol 25:713-4. 2011..This field, therefore, should focus more on further schizophrenia research...
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatmentNorbert Muller
Department of Psychiatry and Psychotherapy, Ludwig Maximilians Universitat Munchen, Germany
Schizophr Res 121:118-24. 2010..In future, further trials are needed to investigate the effect of COX-2 inhibitors on prodromal and negative symptoms of schizophrenia...
Inflammatory biomarkers and depressionNorbert Muller
Department of Psychiatry and Psychotherapy, Ludwig Maximilians Universitat Munchen, Nußbaumstr 7, 80336 Munchen, Germany
Neurotox Res 19:308-18. 2011....
Anti-inflammatory therapy with a COX-2 inhibitor in Tourette's syndromeNorbert Muller
Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat Munchen, D 80336 MUnchen, Germany
Inflammopharmacology 12:271-5. 2004..This result of the treatment with a COX-2 inhibitor supports the view that COX-2 inhibitors show therapeutic benefit in patients suffering from psychiatric disorders in which an inflammatory process is involved in the pathophysiology...
Psychotropic effects of COX-2 inhibitors--a possible new approach for the treatment of psychiatric disordersN Muller
Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Nussbaumstrasse 7, 80336 Munich, Germany
Pharmacopsychiatry 37:266-9. 2004..These preliminary clinical data are encouraging for therapeutic effects of the selective COX-2 inhibitors in psychiatric disorders, although these effects have to be confirmed in bigger clinical studies...
[Immunology in schizophrenic disorders]N Muller
Klinik fur Psychiatrie und Psychotherapie, Ludwig Maximilians Universitat, Nussbaumstrasse 7, 80336 Munchen
Nervenarzt 78:253-6, 258-60, 262-3. 2007..This model describes the pathway of immune-mediated glutamatergic-dopaminergic dysregulation, which may lead to the clinical symptoms of schizophrenia. Therapeutic consequences (e.g. cyclo-oxygenase-2 inhibitors) are discussed...
The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatmentNorbert Muller
Department of Psychiatry and Psychotherapy, Ludwig Maximilians Universitat Munchen, Germany
Dialogues Clin Neurosci 11:319-32. 2009..COX-2 inhibitors have been tested in animal models of depression and in preliminary clinical trials, pointing to favorable effects in schizophrenia and in MD...
Duloxetine in the treatment of major psychiatric and neuropathic disordersNorbert Muller
Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians University, 80336 Munich, Germany
Expert Rev Neurother 8:527-36. 2008..Due to duloxetine's properties, a wide range of use will be encountered in the mid-to-long term...
Mechanisms of relapse prevention in schizophreniaN Muller
Department of Psychiatry and Psychotherapy, Ludwig Maximilians University, Nussbaumstrasse 7, 80336 Munich, Germany
Pharmacopsychiatry 37:S141-7. 2004..Moreover, the risk for chronic disorder increases with every relapse of the patient. Therefore relapse prevention is a primary focus in the treatment of schizophrenia...
A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disordersNorbert Muller
Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Nubbaumstr 7, 80336, Munich, Germany
Eur Arch Psychiatry Clin Neurosci 258:97-106. 2008....
Inflammation and the glutamate system in schizophrenia: implications for therapeutic targets and drug developmentNorbert Muller
Ludwig Maximilians University, Hospital for Psychiatry and Psychotherapy, Nussbaumstr 7, 80336 Munich, Germany
Expert Opin Ther Targets 12:1497-507. 2008..Therefore, other therapeutic targets than dopaminergic and serotonergic neurotransmitters are being considered...
[Immunological aspects of depressive disorders]N Muller
Klinik fur Psychiatrie und Psychotherapie, Ludwig Maximilians Universitat, Nussbaumstrasse 7, 80336 Munchen
Nervenarzt 78:1261-73. 2007..The further search for new antidepressant therapeutic mechanisms should take into regard anti-inflammatory substances, e.g. cyclo-oxygenase-2 (COX-2)-inhibitors...
Tourette's syndrome: clinical features, pathophysiology, and therapeutic approachesNorbert Muller
Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Munich, Germany
Dialogues Clin Neurosci 9:161-71. 2007..Moreover, therapeutic strategies using typical and atypical antipsychotics, and also experimental therapies such as repetitive transcranial magnetic stimulation and deep brain stimulation, are critically discussed...
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depressionN Muller
Department for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat Munchen, Munchen, Germany
Mol Psychiatry 12:988-1000. 2007....
Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmissionN Muller
Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, 80336 Munchen, Germany
Neurotox Res 10:131-48. 2006..Therapeutic consequences, e.g., the use of anti-inflammatory cyclo-oxygenase-2 inhibitors, which can also decrease KYNA directly, are discussed...
COX-2 inhibition in schizophrenia and major depressionNorbert Muller
Department of Psychiatry and Psychotherapy, Ludwig Maximilians Universitat Munchen, Germany
Curr Pharm Des 14:1452-65. 2008....
Effect of aripiprazole on cognition in the treatment of patients with schizophreniaM Riedel
Department of Psychiatry and Psychotherapy, Ludwig Maximilians University, Munich, Germany
Pharmacopsychiatry 43:50-7. 2010..The aim of this study was to assess the cognitive effects of aripiprazole in inpatients with schizophrenia...
Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatmentR Musil
Psychiatric Clinic of University Munich, Nussbaumstrasse 7, 80336 Munich, Germany
J Affect Disord 134:217-25. 2011....
Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130S Stubner
Department of Psychiatry, Ludwig Maximillian University, Munich, Germany
Neurosci Lett 259:145-8. 1999..We found statistically significant decreased CSF concentrations of IL-6 (P<0.001) and of the sIL-6R (P<0.001) of patients with MD. Levels of sgp130 showed no statistically significant difference between patients and controls...
Risperidone plasma levels, clinical response and side-effectsMichael Riedel
Dept of Psychiatry and Psychotherapy, University of Munich, 80336 Munich, Germany
Eur Arch Psychiatry Clin Neurosci 255:261-8. 2005..We thus prospectively investigated risperidone serum concentrations in relation to clinical efficacy and side-effects and genotyped major CYP2D6 polymorphisms to determine their effect upon these parameters...
First-episode schizophrenics show normal duration and topography of quasistationary EEG segments as compared to controls, during rest as well as during active tasksA Stevens
Klinik fur Psychiatrie und Psychotherapie, Universitat Tubingen, Germany
Psychiatry Res 91:111-20. 1999....
Cellular and humoral immune system in schizophrenia: a conceptual re-evaluationN Muller
Department of Psychiatry, Ludwig Maximilians University, Nussbaumstr 7, 80336 Munich, Germany
World J Biol Psychiatry 1:173-9. 2000..During therapy with antipsychotics, the specific TH-1 related immune answer becomes activated, but the B-cell system and the antibody production become activated too...
Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trialH J Moller
Department of Psychiatry, Ludwig Maximilians University, Nussbaumstrasse 7, 80336 Munich, Germany
Pharmacopsychiatry 37:270-8. 2004..Zotepine, a D (2)5HT (2A) antagonist, was compared to placebo in this clinical trial to address these issues...
Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidoneM Riedel
Department of Psychiatry and Psychotherapy, Ludwig Maximilians University Munich, Munich, Germany
Hum Psychopharmacol 25:116-25. 2010..To examine influencing variables of neurocognition in patients with schizophrenia and to predict cognition during antipsychotic treatment...
Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's diseaseH Hampel
Department of Psychiatry, Ludwig Maximilian University, School of Medicine, Munich, Germany
Neurosci Lett 228:143-6. 1997..We suggest that combined measurement of all parameters of the IL-6-receptor complex could yield more insight in a probably altered IL-6 function...
The role of immune function in schizophrenia: an overviewN Muller
Psychiatrische Klinik, Ludwig Maximilians Universitat, Munchen
Eur Arch Psychiatry Clin Neurosci 249:62-8. 1999..During antipsychotic therapy with neuroleptics, the specific TH-1 related immune answer becomes activated, but also the B-cell system and the antibody production increases...
Digitized analysis of abnormal hand-motor performance in schizophrenic patientsP Tigges
Department of Psychiatry, Ludwig Maximilians University Munich, Clinical Neurophysiology Section, Nussbaumstrasse 7, D 80336, Munich, Germany
Schizophr Res 45:133-43. 2000..Our findings show NSS in schizophrenic patients, independently of neuroleptics. Further, the hypothesis of lateralization of cerebral structures generating NSS towards the right hemisphere in schizophrenia is supported...
Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophreniaN Muller
Psychiatric Hospital, Ludwig Maximillian University, Munich, Germany
Am J Psychiatry 156:634-6. 1999....
The immune system and schizophrenia. An integrative viewN Muller
Psychiatric Hospital, Ludwig Maximilian University, Munich, Germany
Ann N Y Acad Sci 917:456-67. 2000..During antipsychotic therapy with neuroleptics, the specific TH-1-related immune answer becomes activated, but in addition the B cell system and antibody production increase...
Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's diseaseH Hampel
Department of Psychiatry, Geriatric Psychiatry Branch, Dementia Research Section, Ludwig Maximilian University Munich, Nussbaumstr 7, 80336, Munich, Germany
Brain Res 823:104-12. 1999....
Increased anti-streptococcal antibodies in patients with Tourette's syndromeN Muller
Department of Psychiatry, Ludwig Maximilian University, Munich, Germany
Psychiatry Res 94:43-9. 2000..Our findings support the theory that a postinfectious immune mechanism may play a role in the pathogenesis of TS. The mechanism still needs to be elucidated...
Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptomsO Pogarell
Department of Psychiatry, University of Munich, Munich, Germany
Pharmacopsychiatry 45:S36-41. 2012....
Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activityGeorg Juckel
Department of Psychiatry, Ludwig Maximilians University, Munich, Germany
Schizophr Res 64:115-24. 2003..These results suggest that the loudness dependence of primary auditory cortex evoked activity is well suitable to assess serotonergic dysfunction in schizophrenia...
Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndromeN Muller
Psychiatric Hospital, Ludwig Maximilian University, Nussbaumstr 7, D 80336, Munchen, Germany
Psychiatry Res 101:187-93. 2001..The finding of a possible autoimmune origin of TS has implications for both pathophysiology and future therapeutic strategies...
How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?M Riedel
Ludwig Maximilians University Munich, Dept of Psychiatry and Psychotherapy, Nussbaumstrasse 7, 80336 Munich, Germany
Eur Arch Psychiatry Clin Neurosci 255:143-8. 2005..Therefore, translation into psychiatric practice may be difficult...
Detection of the novel cell adhesion molecule MUC18 in human brain tissueH Hampel
Department of Psychiatry, Ludwig Maximilian University, Munich, Germany
Neuroimmunomodulation 4:57-61. 1997....
P300 and symptom improvement in schizophreniaJ Gallinat
Department of Psychiatry, Laboratory of Clinical Psychophysiology, Free University Berlin, Eschenallee 3, 14050 Berlin, Germany
Psychopharmacology (Berl) 158:55-65. 2001..A reduced amplitude of the auditory evoked P300 was interpreted as a trait marker of schizophrenia but reports about correlations between schizophrenic psychopathology and P300 amplitude indicate also a state character...
No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophreniaMichael Riedel
Psychiatric Hospital, Ludwig Maximilian University Munich, Nussbaumstr 7, 80336 Munich, Germany
Eur Arch Psychiatry Clin Neurosci 252:232-4. 2002..9 % polymorphic allele). Moreover, we did not find any association between genotype and psychopathology, as measured by PANSS. The different results between these two studies may be due to ethnic differences...
Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophreniaN Muller
Psychiatric Hospital, Ludwig Maximilian University, Munich, Germany
Eur Arch Psychiatry Clin Neurosci 247:308-13. 1997..This suggests that neuroleptic therapy has a differentiated immunomodulatory effect...
CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosisF Padberg
Department of Psychiatry, Ludwig Maximilian University, Munich, Germany
J Neuroimmunol 99:218-23. 1999..Furthermore, sgp130 CSF levels were decreased in MS, suggesting a possibly altered IL-6 regulation in the CSF...
The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanismsM J Schwarz
Psychiatric Hospital, University of Munich, Munich, Germany
Med Hypotheses 56:483-6. 2001..Besides the immunological abnormalities, this subgroup is further characterized by more pronounced negative symptoms and poor therapy outcome. There is evidence that this subgroup might be caused by a prenatal viral infection...
Antibodies to heat shock proteins in schizophrenic patients: implications for the mechanism of the diseaseM J Schwarz
Psychiatric Hospital, Department of Neurochemistry, Psychiatric Hospital, Ludwig Maximilian University Munich, Germany
Am J Psychiatry 156:1103-4. 1999..To elucidate their role in schizophrenia, the authors investigated antibody titers to heat shock proteins in unmedicated and medicated patients with schizophrenia...
T-cell subsets and expression of integrins in peripheral blood of patients with migraineM Empl
Department of Neurology, University of Munich, Germany
Cephalalgia 19:713-7; discussion 697. 1999..5 +/- 12.0%; p < 0.01). These preliminary results support the hypothesis that immunological mechanisms (such as an enhanced lymphocyte endothelium interaction) could be part of the migraine pathophysiology in humans...
Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophreniaM J Schwarz
Department of Neurochemistry, University of Munich, Germany
Neurosci Lett 253:201-3. 1998..A BCB impairment was associated with high levels of sICAM-1. Our data indicate an inflammatory mechanism of BCB impairment in schizophrenics and should enrich the discussion on an expanded immunological diagnosis in schizophrenia...
Melanoma-associated adhesion molecule MUC18/MCAM (CD146) and transcriptional regulator mader in normal human CNSM J Schwarz
Department of Neurochemistry, Psychiatric Hospital, University of Munich, Germany
Neuroimmunomodulation 5:270-6. 1998..These observations may have important implications for further studies investigating their possible roles in cell adhesion and proliferation control within the CNS...
Health-related quality of life in patients with Gilles de la Tourette's syndromeKirsten Muller-Vahl
Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Germany
Mov Disord 25:309-14. 2010..The main independent factors for determining HrQoL were depression, severity of symptoms, and age. Although, treatment of tics is important, co-morbidities such as depression should be diagnosed and treated vigorously...
Therapy-refractory Tourette syndrome: beneficial outcome with globus pallidus internus deep brain stimulationSandra Dehning
Department of Psychiatry and Psychotherapy, Ludwig Maximilians University, Munich, Germany
Mov Disord 23:1300-2. 2008..We report on a female patient with Tourette syndrome and a 12-month follow-up after chronic deep brain stimulation in the globus pallidus internus which resulted in excellent remission of motor and vocal tics...
The association of infectious agents and schizophreniaDaniela Krause
Department of Psychiatry and Psychotherapy, Ludwig Maximilians University, Munich, Germany
World J Biol Psychiatry 11:739-43. 2010..However most of the studies have only focused on one single pathogen and not on the impact of different infectious agents. We investigated the association between schizophrenia and various neurotophic infectious agents...
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychoticsIlja Spellmann
Department of Psychiatry and Psychotherapy, Ludwig Maximilians University of Munich, Nussbaumstrasse 7, 80336, Munich, Germany
Eur Arch Psychiatry Clin Neurosci 258:335-44. 2008....
SNAP-25 gene polymorphisms and weight gain in schizophrenic patientsRichard Musil
Psychiatric Clinic of University Munich, Nussbaumstrasse 7, 80336 Munich, Germany
J Psychiatr Res 42:963-70. 2008..In conclusion our study can at least partly replicate the previous findings concerning the impact of SNAP-25 gene polymorphisms on weight gain during antipsychotic treatment...
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptomsMichael Riedel
Ludwig Maximilians University of Munich, Dept of Psychiatry and Psychotherapy, Nussbaumstrasse 7, 80336, Munich, Germany
Eur Arch Psychiatry Clin Neurosci 255:432-7. 2005..Quetiapine is also well tolerated, with a lower incidence of EPS and prolactin increase than risperidone...
[Schizophrenic patients in the family practice]Michael Riedel
Klinik für Psychiatrie und Psychotherapie der Universität München
MMW Fortschr Med 149:98-101. 2007..Negative symptoms still represent a therapeutic challenge, especially in conjunction with chronic residual symptoms...
Association between intracellular infectious agents and Tourette's syndromeDaniela Krause
Department of Psychiatry, Ludwig Maximilians University Munich, Munich, Germany
Eur Arch Psychiatry Clin Neurosci 260:359-63. 2010..It still remains unclear whether tic symptoms are partly due to the infection or to changes in the immune balance caused by an infection...
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptomsMichael Riedel
Department of Psychiatry and Psychotherapy, Ludwig Maximilians University of Munich, Nussbaumstrasse 7, 80336, Munich, Germany
Eur Arch Psychiatry Clin Neurosci 257:360-70. 2007..Also, the improvements in cognition following treatment with quetiapine and risperidone may enhance long-term outcomes for these patients...
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophreniaMichael Riedel
Dept of Psychiatry and Psychotherapy, Ludwig Maximilians University of Munich, Nussbaumstrasse 7, 80336 Munich, Germany
Eur Arch Psychiatry Clin Neurosci 257:402-12. 2007..Furthermore, quetiapine produced a significantly greater improvement in reaction quality/attention than olanzapine...
Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusing on MIF and CD14 gene polymorphismsLarissa de la Fontaine
Klinik fur Psychiatrie und Psychotherapie, Nussbaumstr 7, Ludwig Maximilians Universitat, D 80336 MUnchen, Germany
Psychiatry Res 144:39-47. 2006....
T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatmentKatja Maino
Department of Psychiatry and Psychotherapy Ludwig Maximilians University, Munchen, Germany
Psychiatry Res 152:173-80. 2007....
Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patientsIlja Spellmann
Department of Psychiatry and Psychotherapy, Ludwig Maximilians University of Munich, Nußbaumstrasse 7, 80336 Munich, Germany
J Psychiatr Res 45:234-41. 2011..Thus, these data might further help in detecting differential therapy response in individuals with schizophrenia...
Comorbidity of Tourette's syndrome and schizophrenia--biological and physiological parallelsNorbert Muller
Hospital for Psychiatry and Psychotherapy, Ludwig Maximilian University, Nussbaumstrasse 7, D 80336 Munich 2, Germany
Prog Neuropsychopharmacol Biol Psychiatry 26:1245-52. 2002..Both disorders show disturbances of the multiple functional pathways, which seem to be involved in the pathophysiology of both. The clinical overlap of TS and of schizophrenia may be due to a final common pathophysiological pathway...
COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapyNorbert Muller
Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Nussbaumstrasse 7, 80336 Munich, Germany
Eur Arch Psychiatry Clin Neurosci 254:14-22. 2004....
COX-2 inhibitors as adjunctive therapy in schizophreniaNorbert Muller
Ludwig Maximilans University, Department of Psychiatry and Psychotherapy, Nussbaumstrasse 7, D 80336 Munich, Germany
Expert Opin Investig Drugs 13:1033-44. 2004..These preliminary clinical data are encouraging for clinical therapeutic effects of the selective COX-2 inhibitors in psychiatric disorders, although these effects have to be confirmed in larger clinical studies...
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophreniaNorbert Muller
Psychiatric and Psychotherapeutic Hospital, Ludwig Maximilians University, Munich, Germany
Am J Psychiatry 159:1029-34. 2002..The authors conducted a trial of the new selective cyclooxygenase-2 inhibitor celecoxib, an immunomodulatory drug, in schizophrenic patients to evaluate its therapeutic effects...
Mycoplasma pneumoniae infection and Tourette's syndromeNorbert Muller
Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians University Munchen, Nussbaumstrasse 7, D 80336 MUnchen, Germany
Psychiatry Res 129:119-25. 2004..An autoimmune reaction, however, has to be taken into account. In predisposed persons, infection with various agents including M. pneumoniae should be considered as at least an aggravating factor in TS...
Internally and externally guided voluntary saccades in unmedicated and medicated schizophrenic patients. Part II. Saccadic latency, gain, and fixation suppression errorsN Muller
Psychiatric Hospital, Ludwig Maximilians University, Munich, Germany
Eur Arch Psychiatry Clin Neurosci 249:7-14. 1999....
Effects of experimentally induced panic attacks on neuroimmunological markersL de la Fontaine
Department of Psychiatry, Ludwig Maximilian University, Nussbaumstr 7, 80336 Munich, Germany
J Neural Transm 116:699-702. 2009..Herein we conducted for the first time a new approach to immunological research in panic disorder, suggesting immune changes are more related to long term disease stress...
[Immunoglobulin therapy in Gilles de la Tourette syndrome]N Muller
Psychiatrische Klinik, Ludwig Maximilians Universitat, Munchen
Nervenarzt 68:914-6. 1997..These findings and the successful therapy underline reports of the literature and point to a pathogenetic mechanism of an immunologically triggered disturbance of the striatal dopaminergic system, at least in a subgroup of GTS...
IL-2 and IL-4 polymorphisms as candidate genes in schizophreniaMarkus J Schwarz
Psychiatric Hospital, Ludwig Maximilian University Munich, Nussbaumstr 7, 80336, Munich, Germany
Eur Arch Psychiatry Clin Neurosci 256:72-6. 2006....
Decreased T cellular immune response in schizophrenic patientsMichael Riedel
Department of Psychiatry and Psychotherapy, Ludwig Maximilians University of Munich, Nussbaumstrasse 7, D 80336 Munich, Germany
J Psychiatr Res 41:3-7. 2007..Our findings demonstrate a markedly attenuated in vivo type-1 mediated cellular immune response in schizophrenic patients, further confirming the hypothesis of a relative Th2 shift in schizophrenia...
COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to dateMichael Riedel
Department of Psychiatry and Psychotherapy, Ludwig-Maximilan University of Munich, Munich, Germany
CNS Drugs 19:805-19. 2005..While the first trial using celecoxib as add-on therapy to an atypical antipsychotic showed a significant beneficial effect, recent studies demonstrated that this effect may be limited to patients with recent-onset schizophrenia...
Functional EEG mapping and SPECT in detoxified male alcoholicsW Gunther
Psychiatric University Hospital, Munich, Germany
Eur Arch Psychiatry Clin Neurosci 247:128-36. 1997..All findings point to organic brain dysfunctions in these patients which extend beyond the period of withdrawal...
Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. Part VI. Evaluation of psychomotor training programs in schizophrenic patientsW Gunther
Psychiatrische Universitatsklinik, Munchen, Germany
Eur Arch Psychiatry Clin Neurosci 245:288-98. 1995..A final version of our complete training programs will be published as an appendix to this paper along with information regarding the abbreviated test battery...
Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markersGerald Stober
Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wurzburg, Wurzburg, Germany
World J Biol Psychiatry 10:127-55. 2009....
ICAM G241A polymorphism and soluble ICAM-1 serum levels: evidence for an active immune process in schizophreniaHolger Kronig
Psychiatric Hospital, Ludwig Maximilian University Munich, Munich, Germany
Neuroimmunomodulation 12:54-9. 2005..The G-->A SNP results in a nonsynonymous amino acid exchange of the ICAM-1 protein, and the A allele was shown to be also associated with several immunological disorders like rheumatoid arthritis...
The work of Emil Kraepelin and his research group in MünchenHanns Hippius
Hospital for Psychiatry and Psychotherapy, Ludwig Maximilians Universitat, Nubbaumstr 7, 80336, Munich, Germany
Eur Arch Psychiatry Clin Neurosci 258:3-11. 2008..This contribution shows that Kraepelin himself questioned his dichotomy of dementia praecox and manic depressive insanity, a discussion which is lively still today--more than 80 years later...
Electroconvulsive therapy in a patient with Tourette's syndrome and co-morbid Obsessive Compulsive DisorderMartin Strassnig
Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Nussbaumstrasse 7, 80336 Munich, Germany
World J Biol Psychiatry 5:164-6. 2004..Monthly outpatient ECT sessions were arranged in order to sustain the positive treatment outcome. Since then, remission of both disorders has been maintained successfully for more than a year...
Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depressionRainald Mossner
Department of Psychiatry and Psychotherapy, University of Wurzburg, Wurzburg, Germany
World J Biol Psychiatry 8:141-74. 2007....
Immunological and infectious aspects of schizophreniaNorbert Muller
Klinik fur Psychiatrie und Psychotherapie, Ludwig Maximilians Universitat, Nussbaumstrasse 7, 80336 Munich, Germany
Eur Arch Psychiatry Clin Neurosci 254:1-3. 2004
